Research Brief · Sleep and Brain Clearance · Plain Language
The Brain’s Night Shift: The Locus Coeruleus, Deep Sleep, and Waste Clearance in APOE4 Carriers
By Brian Paquette, DO, MPH
A tiny cluster of brainstem cells may help explain why deep sleep matters so much for brain health. A new review in Neurology from Mayo Clinic describes how this cluster, the locus coeruleus, may act as the conductor of a nightly rinse cycle that flushes waste such as amyloid out of the brain. For APOE4 carriers, that system may deserve special attention.
The short answer
What does this mean if you carry APOE4?
| MECHANISM | During non-REM sleep, the locus coeruleus cycles roughly every 30 to 50 seconds. In mice, each cycle squeezes and relaxes small arteries, pumping fluid through the brain to carry waste away. |
| APOE4 LINK | Carriers may be more vulnerable when clearance is low. In one cross-sectional study, a weaker clearance marker tracked with more amyloid only in carriers, and carriers lose deep sleep faster with age. |
| ACTION | Protect deep sleep and blood vessel health. Treat sleep apnea, control blood pressure, and time caffeine wisely. |
| CAUTION | Much of the mechanism comes from mouse studies, and even those findings are debated. No trial yet shows that improving sleep prevents Alzheimer’s in carriers. |
A small brainstem nucleus with a big job
The locus coeruleus (LC) is a pair of tiny nuclei in the brainstem. It is the brain’s main source of norepinephrine, the chemical messenger that keeps us alert and focused during the day. It is also one of the first places where tau, the protein that forms Alzheimer’s tangles, appears, often decades before symptoms.
Castillo and Benarroch’s 2026 review in Neurology pulls together recent evidence that the LC does important work at night as well.1 Rather than switching off, the LC changes its rhythm during non-REM sleep. Norepinephrine levels rise and fall in slow cycles that repeat about every 30 to 50 seconds. In humans, this slow cycling appears more prominent in lighter (N2) non-REM sleep than in the deepest stage (N3).1
How the brain takes out the trash
The brain has no conventional lymphatic vessels within its tissue. Instead it relies on the glymphatic system, in which cerebrospinal fluid flows in along the outside of arteries, mixes with the fluid between brain cells, and drains out along veins. That fluid carries amyloid-β, tau, and other waste products with it.
A landmark 2025 mouse study in Cell (Hauglund and colleagues) showed that the slow norepinephrine cycles from the LC make small arteries rhythmically tighten and relax.2 That motion acts like a pump, pushing fluid through the brain. The review highlights three further points:
Clearance peaks in deep (N3) slow-wave sleep. In mice, the space between brain cells expands by about 60% during sleep, which lets fluid and waste move more freely.1
Sleep loss works against the system. In mice, sleep deprivation disrupts aquaporin-4, the water channel on support cells (astrocytes) that the glymphatic system depends on.1 Notably, one mouse study found this effect in animals carrying human APOE4 but not APOE3.3
More sedation is not the same as better clearance. In the 2025 mouse study, the sleep medication zolpidem dampened the norepinephrine cycles and reduced fluid flow.2 The review authors note that the ideal amount of LC activity during sleep is likely a middle ground, neither too much nor too little.1
This model is not settled. A 2024 mouse study in Nature Neuroscience reported reduced, rather than increased, brain clearance during sleep and anesthesia, and researchers are still working out why results differ.4
Why this matters for APOE4 carriers
The Neurology review does not focus on APOE4. But several peer-reviewed studies connect APOE4 to links in this chain.
1. Carriers may be more sensitive to weak clearance
In a cross-sectional study of 423 older adults, Kang and colleagues used the DTI-ALPS index, a proposed, indirect MRI marker of glymphatic function. A lower index was associated with more brain amyloid only in APOE4 carriers; no such carrier-specific pattern was seen for tau.5 This suggests carriers may have less margin for error when clearance slows. The marker itself is still being validated, and it does not correlate closely with more direct contrast-based measures.6
2. Carriers lose deep sleep faster
In the Framingham Heart Study, deep slow-wave sleep declined with age, and the decline was faster in APOE4 carriers. Separately, across all participants, each additional percentage-point yearly loss of slow-wave sleep was associated with a 27% higher dementia risk over 17 years, regardless of APOE4 status.7
3. APOE4 may directly stress the locus coeruleus
Laboratory and animal work suggests the ApoE4 protein interferes with how LC neurons store norepinephrine. This leads to a toxic breakdown product that promotes harmful processing of tau.8 In cognitively normal adults with brain amyloid from the A4 study, short sleep and APOE4 together were linked to altered LC connectivity, which in turn related to memory performance, in a cross-sectional analysis.9
Taken together, these findings point to a possible vicious cycle. APOE4 may strain the LC and slow clearance. Reduced clearance may allow amyloid and tau to build up. That buildup may damage the LC further and fragment sleep. Because poor sleep can be both a cause and an early consequence of Alzheimer’s changes, the direction of these links in people is not yet clear.10
Practical steps supported by current evidence
Screen for and treat sleep apnea. Loud snoring, witnessed pauses in breathing, or daytime sleepiness warrant evaluation. Untreated obstructive sleep apnea is linked to cognitive impairment.11 In rodent studies, positive airway pressure (CPAP) increased brain fluid flow,12 and a small human study found improved MRI drainage measures after one month of CPAP.13
Prioritize regular, sufficient sleep. Deep sleep is concentrated in the first half of the night, so consistent bedtimes and about 7 to 8 hours of actual sleep help protect it. Both short (under 7 hours) and very long (over 9 hours) sleep have been linked to higher dementia risk.14
Time caffeine carefully. Caffeine blocks receptors for adenosine, the brain’s main sleep-pressure signal, and can reduce slow-wave sleep, which could indirectly affect clearance.1 Avoiding it in the afternoon and evening is a reasonable precaution.
Protect your arteries. The glymphatic pump relies on small arteries that can rhythmically constrict and relax.1 It is plausible, though not yet proven in people, that healthy blood vessels support this system. Blood pressure control, regular aerobic exercise, not smoking, and good metabolic health are worthwhile for brain health in any case.
Review sleep medications with your physician. Do not stop a prescribed medication on your own. Mouse data alone do not establish harm in people, but it is worth asking whether a sedative is still needed, or whether options such as cognitive behavioral therapy for insomnia (CBT-I) are appropriate.
The bottom line for carriers: Deep sleep appears to be an active cleaning period for the brain, and the locus coeruleus appears to help drive it. APOE4 carriers may be more vulnerable when this system weakens. Sleep quality is not a guarantee against Alzheimer’s, but it is a plausible and modifiable target, and a reasonable place to focus while human trials catch up with the biology.
Terms and acronyms used in this article
| Term | What it means |
| Locus coeruleus (LC) | A small brainstem nucleus that supplies most of the brain’s norepinephrine. |
| Norepinephrine (NE) | A chemical messenger involved in alertness, attention, and blood vessel tone. |
| Glymphatic system | The brain’s fluid-based waste clearance pathway, most active during deep sleep. |
| Slow-wave sleep (N3) | The deepest stage of non-REM sleep. |
| Aquaporin-4 (AQP4) | A water channel on astrocytes that helps fluid move through brain tissue. |
| DTI-ALPS | An MRI-based index used as an indirect estimate of glymphatic function. |
| CPAP | Continuous positive airway pressure, the standard treatment for obstructive sleep apnea. |
| CBT-I | Cognitive behavioral therapy for insomnia, a first-line non-drug treatment. |
| A4 | Anti-Amyloid Treatment in Asymptomatic Alzheimer’s, a study of people without symptoms who had brain amyloid. |
This article is for education and does not substitute for individualized medical evaluation.
References
1. Castillo PR, Benarroch E. What is the role of the locus coeruleus in sleep, cerebrovascular control, and glymphatic clearance? Neurology. 2026;107(8):e218662. doi:10.1212/WNL.0000000000218662
2. Hauglund NL, Andersen M, Tokarska K, et al. Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep. Cell. 2025;188(3):606–622.e17. doi:10.1016/j.cell.2024.11.027
3. Wang C, Nambiar A, Strickland MR, et al. APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading. J Clin Invest. 2023;133(14):e169131. doi:10.1172/JCI169131
4. Miao A, Luo T, Hsieh B, et al. Brain clearance is reduced during sleep and anesthesia. Nat Neurosci. 2024;27(6):1046–1050. doi:10.1038/s41593-024-01638-y
5. Kang KM, Park C, Byun MS, et al. APOE4 modulates the association between DTI-ALPS index and Alzheimer’s pathologies. Alzheimers Dement. 2025;21(10):e70837. doi:10.1002/alz.70837
6. Mossige I, Valnes LM, Storås TH, et al. Comparing glymphatic function measures: diffusion tensor image analysis along perivascular spaces (DTI-ALPS) versus intrathecal contrast-enhanced MRI. Radiology. 2026;318(2):e252070. doi:10.1148/radiol.252070
7. Himali JJ, Baril AA, Cavuoto MG, et al. Association between slow-wave sleep loss and incident dementia. JAMA Neurol. 2023;80(12):1326–1333. doi:10.1001/jamaneurol.2023.3889
8. Kang SS, Ahn EH, Liu X, et al. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates tau pathology in Alzheimer’s disease. Acta Neuropathol. 2021;142(1):139–158. doi:10.1007/s00401-021-02315-1
9. Gong L, Li H, Li M, et al. APOE genotype modulates the impact of sleep duration on locus coeruleus functional connectivity in pre-clinical Alzheimer’s disease. Brain Commun. 2025;7(5):fcaf341. doi:10.1093/braincomms/fcaf341
10. Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors. Neuropsychopharmacology. 2020;45(1):104–120. doi:10.1038/s41386-019-0478-5
11. Lal C, Ayappa I, Ayas N, et al. The link between obstructive sleep apnea and neurocognitive impairment: an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2022;19(8):1245–1256. doi:10.1513/AnnalsATS.202205-380ST
12. Ozturk B, Koundal S, Al Bizri E, et al. Continuous positive airway pressure increases CSF flow and glymphatic transport. JCI Insight. 2023;8(12):e170270. doi:10.1172/jci.insight.170270
13. Wang J, Tian Y, Qin C, et al. Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction. J Neurol. 2023;270(4):2204–2216. doi:10.1007/s00415-022-11530-z
14. Gottesman RF, Lutsey PL, Benveniste H, et al. Impact of sleep disorders and disturbed sleep on brain health: a scientific statement from the American Heart Association. Stroke. 2024;55(3):e61–e76. doi:10.1161/STR.0000000000000453
